Bookmark and Share
2-butenal (CID 447466) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(3)
 
 
Inactive(154)
 
 
Inconclusive(6)
 
 
Unspecified(1)
 
 
Top Targets:
NR LBD PPAR(5)
 
 
NR LBD TR(4)
 
 
HSD10-like SD..(4)
 
 
NR LBD ROR li..(3)
 
 
P53(3)
 
 
BioAssay Types:
Confirmatory(150)
 
 
 
Literature(3)
 
 
 
BioActivity Types:
Potency(114)
 
 
 
EC50(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 152    Data Row: 164   Total Pages: 9   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103756899]
EC50 16Activation of TRPA1 channel [AID482142, Type: Literature]
View
2
[SID48413490]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
3
[SID48413490]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
4
[SID17389091]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
5
[SID17389091]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_1, Type: other]
View
6
[SID17389091]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_2, Type: other]
View
7
[SID17389091]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_3, Type: other]
View
8
[SID17389091]
Potency Cell Viability - LYMP1-002 - Assay at 40 hr [AID994, Type: confirmatory]
View
9
[SID17389091]
Potency qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia [AID1477, Type: confirmatory]
View
10
[SID17389091]
Potency qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory]
View
11
[SID17389091]
Potency qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory]Arachidonate 15-lipoxygenase B [gi:317373425]
View
12
[SID17389091]
Potency qHTS assay for small molecule agonists of retinoid X receptor alpha signaling [AID588544, Type: confirmatory]retinoid X nuclear receptor alpha [Homo sapiens] [gi:325495497]
View
13
[SID17389091]
Potency Cell Viability - LYMP2-018 [AID985, Type: confirmatory]
View
14
[SID17389091]
Potency Cell Viability - LYMP2-020 [AID986, Type: confirmatory]
View
15
[SID17389091]
Potency Cell Viability - LYMP2-022 [AID987, Type: confirmatory]
View
16
[SID17389091]
Potency Cell Viability - LYMP2-024 [AID988, Type: confirmatory]
View
17
[SID17389091]
Potency Cell Viability - LYMP2-026 [AID989, Type: confirmatory]
View
18
[SID17389091]
Potency Cell Viability - LYMP1-002 - Assay at 24 hr [AID993, Type: confirmatory]
View
19
[SID17389091]
Potency Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
20
[SID17389091]
Potency Cell Viability - LYMP2-008 [AID980, Type: confirmatory]
View